Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Dérivé de la dibenzothiazépine")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 346

  • Page / 14
Export

Selection :

  • and

Disabling chronic cough successfully treated with quetiapine: A case reportCOMPARELLI, Anna; LELLI-CHIESA, Giovanni; KOTZALIDIS, Giorgio D et al.Progress in neuro-psychopharmacology & biological psychiatry. 2010, Vol 34, Num 1, pp 254-255, issn 0278-5846, 2 p.Article

Quetiapine prevents anhedonia induced by acute or chronic stressORSETTI, Marco; LUIGI CANONICO, Pier; DELLAROLE, Anna et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 8, pp 1783-1790, issn 0893-133X, 8 p.Article

Tardive Oculogyric Crisis Associated With Quetiapine UseGHOSH, Soumitra; DHRUBAJYOTI, Bhuyan; BHATTACHARYA, Arnab et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 2, issn 0271-0749, p. 266Article

Dose-related exacerbation of obsessive : compulsive symptoms with quetiapine treatmentCHEN, Chia-Hui; CHIU, Chi-Chiang; HUANG, Ming-Chyi et al.HUANG, Ming-Chyi et al.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 1, pp 304-305, issn 0278-5846, 2 p.Article

Relationship Between Daily Dose, Plasma Concentrations, Dopamine Receptor Occupancy, and Clinical Response to Quetiapine: A ReviewSPARSHATT, Anna; TAYLOR, David; PATEL, Maxine X et al.The Journal of clinical psychiatry. 2011, Vol 72, Num 8, pp 1108-1123, issn 0160-6689, 16 p.Article

Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorderFOND, Guillaume; MACGREGOR, Alexandra; DUCASSE, Deborah et al.Psychiatry research (Print). 2014, Vol 216, Num 2, pp 286-287, issn 0165-1781, 2 p.Article

Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelinationYANBO ZHANG; HANDI ZHANG; JUE HE et al.Schizophrenia research. 2012, Vol 138, Num 1, pp 8-17, issn 0920-9964, 10 p.Article

Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobiaDONAHUE, Christopher B; KUSHNER, Matt G; THURAS, Paul D et al.Journal of anxiety disorders. 2009, Vol 23, Num 3, pp 362-368, issn 0887-6185, 7 p.Article

Acute Quetiapine Overdose in Adults : A 5-Year Retrospective Case SeriesNGO, Adeline; CIRANNI, Michael; OLSON, Kent R et al.Annals of emergency medicine. 2008, Vol 52, Num 5, pp 541-547, issn 0196-0644, 7 p.Article

N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-HTIA Agonist, as a Putative Mediator of Quetiapine's Antidepressant ActivityJENSEN, Niels H; RODRIGUIZ, Ramona M; CARON, Marc G et al.Neuropsychopharmacology (New York, NY). 2008, Vol 33, Num 10, pp 2303-2312, issn 0893-133X, 10 p.Article

Quetiapine for elderly non-responsive schizophrenia patientsMAZEH, Doron; PALEACU, Diana; BARAK, Yoram et al.Psychiatry research. Neuroimaging. 2007, Vol 157, Num 1-3, pp 265-267, issn 0925-4927, 3 p.Article

The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescentsPODOBNIK, Josip; FOLLER PODOBNIK, Iris; GRGIC, Neda et al.Psychopharmacologia. 2012, Vol 220, Num 3, pp 639-641, issn 0033-3158, 3 p.Article

Pharmacokinetic Variability of Quetiapine and the Active Metabolite N-desalkylquetiapine in Psychiatric PatientsVIBEKE BAKKEN, Gry; RUDBERG, Ida; MOLDEN, Espen et al.Therapeutic drug monitoring. 2011, Vol 33, Num 2, pp 222-226, issn 0163-4356, 5 p.Article

Long-term effectiveness of quetiapine in bipolar disorder in a clinical settingKETTER, Terence A; BROOKS, John O; HOBLYN, Jennifer C et al.Journal of psychiatric research. 2010, Vol 44, Num 14, pp 921-929, issn 0022-3956, 9 p.Article

Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B5BAKKEN, Gry Vibeke; RUDBERG, Ida; CHRISTENSEN, Hege et al.Drug metabolism and disposition. 2009, Vol 37, Num 2, pp 254-258, issn 0090-9556, 5 p.Article

Effectiveness of quetiapine in rapid cycling bipolar disorder : A preliminary studyGOLDBERG, Joseph F; KELLEY, Mary E; ROSENQUIST, Klara J et al.Journal of affective disorders. 2008, Vol 105, Num 1-3, pp 305-310, issn 0165-0327, 6 p.Article

Neurochemical Effects of Quetiapine in Patients With Bipolar Mania: A Proton Magnetic Resonance Spectroscopy StudyADLER, Caleb M; DELBELLO, Melissa P; WEBER, Wade A et al.Journal of clinical psychopharmacology. 2013, Vol 33, Num 4, pp 528-532, issn 0271-0749, 5 p.Article

Plasma Concentrations of Quetiapine, N-Desalkylquetiapine, O-Desalkylquetiapine, 7-Hydroxyquetiapine, and Quetiapine Sulfoxide in Relation to Quetiapine Dose, Formulation, and Other FactorsFISHER, Danielle S; HANDLEY, Simon A; FLANAGAN, Robert J et al.Therapeutic drug monitoring. 2012, Vol 34, Num 4, pp 415-421, issn 0163-4356, 7 p.Article

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized studyBORTNICK, Brian; EL-KHALILI, Nizar; BANOV, Michael et al.Journal of affective disorders. 2011, Vol 128, Num 1-2, pp 83-94, issn 0165-0327, 12 p.Article

Prepulse inhibition of the startle reflex in schizophrenia remains stable with short-term quetiapineMOLINA, V; LOPEA, D. E; VILLA, R et al.European psychiatry. 2011, Vol 26, Num 5, pp 271-275, issn 0924-9338, 5 p.Article

Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disordersIGUE, Raouf; POTVIN, Stéphane; BAH, Ramatoulaye et al.Progress in neuro-psychopharmacology & biological psychiatry. 2011, Vol 35, Num 7, pp 1695-1698, issn 0278-5846, 4 p.Article

Statistically Significant Increase in Weight Caused by Low-Dose QuetiapineWILLIAMS, Scott G; ALINEJAD, Nima A; WILLIAMS, Jeannie A et al.Pharmacotherapy. 2010, Vol 30, Num 10, pp 1011-1015, issn 0277-0008, 5 p.Article

Quetiapine XR: Current status for the treatment of major depressive disorderPAE, Chi-Un; MANMOHANDEEP SINGH SOHI; SEO, Ho-Jun et al.Progress in neuro-psychopharmacology & biological psychiatry. 2010, Vol 34, Num 7, pp 1165-1173, issn 0278-5846, 9 p.Article

Identification and Characterization of Potential Impurities of Quetiapine FumarateSTOLARCZYK, Elzbieta U; KACZMAREK, Lukasz; EKSANOW, Kamil et al.Pharmaceutical development and technology. 2009, Vol 14, Num 1, pp 27-37, issn 1083-7450, 11 p.Article

Quetiapine Extended-Release Versus Immediate-Release Formulation : A Positron Emission Tomography StudyMAMO, David C; UCHIDA, Hiroyuki; VITCU, Irina et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 1, pp 81-86, issn 0160-6689, 6 p.Article

  • Page / 14